6Packer M, CheorghiadeM, Young J, et al. Withdrawal of digoxin, from patients with chronic heart failure treated with angiotensin - convertionen - zyme inhibitors N Engl J Med, 1993,329 : 1 - 7.
6Gaspoz JM. Costs and benefits of heart failure treatment. SchweizMed Wochenschr, 1999,129(4):131.
7Connor CM, Gattis WA, Swedberg K. Current and novel Pharma-cologic approaches in advanced heart failure. Am Heart J, 1998 ,135(6 Pt 2 Su):S249.
8Coodley E. Newer drug therapy for congestive heart failure. ArchIntern Med 1999 , 159(11): 1177.
9Unterberg C, Kreuzer H, Buchwald AB. The renin-angiotensin sys-tem in cardiovascular diseases. Med Klin, 1998, 93(7):416.
10Garg R, Yusuf S. Overview of randomized trials of angiotensin-con-vetting enzyme inhibitors on mortality and morbidity in patients withheart failure. Collaborative Group on ACE Inhibitor Trials. JAMA,1995, 273(18): 1450.
